Cargando…
Rosiglitazone use and associated adverse event rates in Canada: an updated analysis
BACKGROUND: We previously reported on the change in the use of rosiglitazone-containing products (RCP) and adverse event reporting rates in Canadian patients between 2004 and 2010. The present study extends this analysis to include the January 2011 to December 2012 time period. METHODS: RCP utilizat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588901/ https://www.ncbi.nlm.nih.gov/pubmed/26419903 http://dx.doi.org/10.1186/s13104-015-1448-6 |